Abeona Therapeutics (ABEO) Competitors $5.74 -0.11 (-1.88%) Closing price 04:00 PM EasternExtended Trading$5.71 -0.03 (-0.45%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO vs. CALT, GPCR, HROW, PAHC, ABCL, NTLA, AMPH, WVE, AUPH, and ARDXShould you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Calliditas Therapeutics AB (publ) (CALT), Structure Therapeutics (GPCR), Harrow (HROW), Phibro Animal Health (PAHC), AbCellera Biologics (ABCL), Intellia Therapeutics (NTLA), Amphastar Pharmaceuticals (AMPH), WAVE Life Sciences (WVE), Aurinia Pharmaceuticals (AUPH), and Ardelyx (ARDX). These companies are all part of the "pharmaceutical products" industry. Abeona Therapeutics vs. Its Competitors Calliditas Therapeutics AB (publ) Structure Therapeutics Harrow Phibro Animal Health AbCellera Biologics Intellia Therapeutics Amphastar Pharmaceuticals WAVE Life Sciences Aurinia Pharmaceuticals Ardelyx Abeona Therapeutics (NASDAQ:ABEO) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability. Do institutionals & insiders believe in ABEO or CALT? 80.6% of Abeona Therapeutics shares are held by institutional investors. Comparatively, 2.8% of Calliditas Therapeutics AB (publ) shares are held by institutional investors. 6.9% of Abeona Therapeutics shares are held by insiders. Comparatively, 2.2% of Calliditas Therapeutics AB (publ) shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, ABEO or CALT? Abeona Therapeutics has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Calliditas Therapeutics AB (publ) has a beta of 1.77, indicating that its share price is 77% more volatile than the S&P 500. Do analysts prefer ABEO or CALT? Abeona Therapeutics currently has a consensus price target of $19.25, indicating a potential upside of 235.37%. Given Abeona Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Abeona Therapeutics is more favorable than Calliditas Therapeutics AB (publ).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abeona Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Calliditas Therapeutics AB (publ) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ABEO or CALT more profitable? Abeona Therapeutics has a net margin of 0.00% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. Abeona Therapeutics' return on equity of -118.82% beat Calliditas Therapeutics AB (publ)'s return on equity.Company Net Margins Return on Equity Return on Assets Abeona TherapeuticsN/A -118.82% -52.48% Calliditas Therapeutics AB (publ) -30.18%-212.04%-27.96% Does the media favor ABEO or CALT? In the previous week, Abeona Therapeutics had 16 more articles in the media than Calliditas Therapeutics AB (publ). MarketBeat recorded 16 mentions for Abeona Therapeutics and 0 mentions for Calliditas Therapeutics AB (publ). Abeona Therapeutics' average media sentiment score of 0.23 beat Calliditas Therapeutics AB (publ)'s score of 0.00 indicating that Abeona Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Abeona Therapeutics Neutral Calliditas Therapeutics AB (publ) Neutral Which has better earnings and valuation, ABEO or CALT? Calliditas Therapeutics AB (publ) has higher revenue and earnings than Abeona Therapeutics. Calliditas Therapeutics AB (publ) is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbeona Therapeutics$3.50M83.90-$63.73M-$1.27-4.52Calliditas Therapeutics AB (publ)$1.60B0.74-$43.96M-$1.85-21.62 SummaryAbeona Therapeutics beats Calliditas Therapeutics AB (publ) on 11 of the 15 factors compared between the two stocks. Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEO vs. The Competition Export to ExcelMetricAbeona TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$299.27M$2.92B$5.52B$9.07BDividend YieldN/A2.43%5.25%4.02%P/E RatioN/A20.7127.7220.26Price / Sales83.90182.01366.7878.98Price / CashN/A42.7337.4258.29Price / Book5.687.638.045.49Net Income-$63.73M-$55.05M$3.18B$250.27M7 Day Performance-2.78%8.54%3.72%4.78%1 Month Performance-7.72%5.38%3.72%7.20%1 Year Performance10.60%2.35%29.92%17.27% Abeona Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEOAbeona Therapeutics3.7766 of 5 stars$5.74-1.9%$19.25+235.4%+17.2%$299.27M$3.50M0.0090Trending NewsInsider TradeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180GPCRStructure Therapeutics2.7319 of 5 stars$18.73-8.0%$76.17+306.7%-54.8%$1.17BN/A0.00136HROWHarrow2.3353 of 5 stars$31.36-1.2%$61.40+95.8%+36.0%$1.16B$199.61M0.00180News CoverageAnalyst ForecastPAHCPhibro Animal Health4.0558 of 5 stars$29.90+6.8%$24.40-18.4%+90.0%$1.13B$1.02B38.331,940High Trading VolumeABCLAbCellera Biologics2.3105 of 5 stars$4.03+6.1%$7.50+86.1%+51.8%$1.13B$28.83M0.00500Analyst RevisionHigh Trading VolumeNTLAIntellia Therapeutics4.3917 of 5 stars$10.25-4.6%$33.37+225.5%-47.5%$1.11B$57.88M-1.96600AMPHAmphastar Pharmaceuticals4.3521 of 5 stars$22.86-1.5%$32.33+41.4%-40.6%$1.09B$731.97M8.282,028WVEWAVE Life Sciences4.5538 of 5 stars$7.06+1.6%$20.50+190.4%+42.7%$1.08B$108.30M-8.40240AUPHAurinia Pharmaceuticals3.1063 of 5 stars$7.47-1.6%$11.50+53.9%+62.4%$1.03B$235.13M26.68300Positive NewsARDXArdelyx4.1434 of 5 stars$4.35+1.9%$10.89+150.3%-15.5%$1.02B$333.61M-19.7790Analyst Revision Related Companies and Tools Related Companies Calliditas Therapeutics AB (publ) Alternatives Structure Therapeutics Alternatives Harrow Alternatives Phibro Animal Health Alternatives AbCellera Biologics Alternatives Intellia Therapeutics Alternatives Amphastar Pharmaceuticals Alternatives WAVE Life Sciences Alternatives Aurinia Pharmaceuticals Alternatives Ardelyx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABEO) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABEO Stock Alerts